<?xml version="1.0" encoding="UTF-8"?>
<p>The human immune system is tightly linked to tumor development. With the increasing impact of tumor on human health, a large number of studies have been undertaken to identify mushroom extracts/fractions/compounds with antitumor activities. Indeed, some of the observed antitumor activities by medicinal mushroom extracts were based on the activation of the immune system (
 <xref rid="jof-06-00269-t002" ref-type="table">Table 2</xref>, 
 <xref rid="jof-06-00269-t003" ref-type="table">Table 3</xref>, 
 <xref rid="jof-06-00269-t004" ref-type="table">Table 4</xref> and 
 <xref rid="jof-06-00269-t005" ref-type="table">Table 5</xref>). Davis et al. (2020) recently suggested that 17 medicinal mushroom species (
 <italic>A. brazei</italic>, 
 <italic>Cordyceps militaris</italic>, 
 <italic>Flammulina velutipe</italic>, 
 <italic>F. fomentarius</italic>, 
 <italic>F. officinalis</italic>, 
 <italic>Ganoderma applanatum</italic>, 
 <italic>G. lucidum</italic>, 
 <italic>Ganoderma oregonense</italic>, 
 <italic>G. frondosa</italic>, 
 <italic>Hericium erinaceus</italic> (syn. 
 <italic>Hericium erinaceum</italic>), 
 <italic>I. obliquus</italic>, 
 <italic>L. edodes</italic>, 
 <italic>Tropicoporus linteus</italic> (syn. 
 <italic>Phellinus linteus</italic>), 
 <italic>P. betulinus</italic>, 
 <italic>Pleurotus ostreatus</italic>, 
 <italic>S. commune</italic>) could support both immune-activation for cancer treatments and help resolve host defense-induced inflammatory reactions and facilitate a post-response return to homeostasis for cancer patients. Furthermore, a medicinal mushroom formulation consisting of 
 <italic>G. lucidum</italic>, 
 <italic>L. edodes</italic> and 
 <italic>G. frondosa</italic> showed synergistic antitumor and immuno-modulatory activity in human macrophages [
 <xref rid="B137-jof-06-00269" ref-type="bibr">137</xref>].
</p>
